Vesicor Therapeutics Appoints Michael Tolentino, M.D., as CEO
Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based cancer therapeutics delivered via precision-engineered microvesicles and...